Tag: Patient risks

FDA announces Class 1 recalls of ventilator, eye injection kits

Editor's Note The US Food & Drug Administration has designated recalls of Baxter’s Life2000 Ventilator and the I-Pack Injection Kit from Bausch + Lomb and subsidiary Synergetics Inc. as Class 1, the most severe category indicating serious risk of injury or death. According to FDA’s July 15 announcement, the ventilator…

Read More

By: Matt Danford
July 16, 2024
Share

Study: Gastric bypass offers cardiovascular benefits regardless of weight loss

Editor's Note Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent of calorie restriction and weight loss, according to a recent study published in JAMA Surgery. News-Medical.Net reported on the study July 4. Bariatric surgery, particularly RYGB, is more effective than non-surgical treatments for significant weight reduction and lowering cardiovascular…

Read More

By: Matt Danford
July 15, 2024
Share

Study: Secondary conditions go unaddressed in female heart surgery patients

Editor's Note Female patients undergoing heart surgery are less likely than male patients to have concomitant procedures—that is, having additional ailments addressed during cardiac procedures—despite guidelines recommending such treatments, according to two studies led by Michigan Medicine. News-Medical.Net reported the news June 28. The first study, involving over 5,000 patients…

Read More

By: Matt Danford
July 3, 2024
Share

FDA announces Class 1 recalls for ventilators, LVAS monitors

Editor's Note The US Food and Drug Administration has announced class 1 recalls—the most severe category indicating risk of serious injury or death—for Abbot Medical’s HeartMate System Monitor and Philips Respironics OmniLab Advanced+ (OLA+) ventilator. According to the agency’s June 28 report, the recall of the HeartMate System Monitor, part…

Read More

By: Matt Danford
July 1, 2024
Share

Standardized handoff protocol improves OR communication

Editor's Note Findings published in the Journal of the American College of Surgeons show how a standardized handoff protocol can improve OR communication and reduce the risk of error, Medical Xpress reported on June 19. The study focused specifically on SHRIMPS, a standardized handoff protocol developed by the quality improvement…

Read More

By: Matt Danford
June 28, 2024
Share

FDA issues Class 1 recalls for two ventilator models

Editor's Note Alarm failures and missing details in instructional materials prompted the US Food and Drug Administration (FDA) to issue class 1 recalls—the most severe category indicating risk of serious injury or death—for two different ventilator models on June 27. According to the report, failure in the Ventilator Inoperative alarm…

Read More

By: Matt Danford
June 28, 2024
Share

Kidney transplant performed on awake patient

Editor's Note In a first for Northwestern Medicine, surgeons performed a kidney transplant on an awake patient, CBS News reported June 24. John Nicholas, 28, of Chicago, experienced no pain during the May 24 procedure, in which he received an organ from a childhood friend. He was discharged the next…

Read More

By: Matt Danford
June 25, 2024
Share

Study: Preoperative weight loss offers little benefit for bariatric surgery patients

Editor's Note Research shows perioperative weight loss does not consistently improve outcomes or OR times in patients undergoing primary bariatric procedures, including laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (RYGB). The findings were published in the June issue of the Journal of the American College of Surgeons. Using…

Read More

By: Matt Danford
June 3, 2024
Share

Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients

Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…

Read More

By: Matt Danford
May 28, 2024
Share

Study: Weight-loss drug semaglutide boosts repeat surgery risk

Editor's Note Popular weight-loss \ drug semaglutide could significantly increase risk for repeat operations patients with diabetes who undergo lumbar surgery. According to a May 8 report in Medscape Medical News, the findings are pending review for publication and reportedly provides the first evidence on the impact of semaglutide on…

Read More

By: Matt Danford
May 17, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat